Heterocyclic compounds for cancer imaging and treatment and methods for their use
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
May 19, 2020
Grant Date -
Nov 15, 2018
app pub date -
Jan 13, 2016
filing date -
Jan 13, 2015
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Compounds having a structure of Formula I: or a pharmaceutically acceptable salt, tautomer or stereoisomer thereof, wherein R1, R2, R3, R11a, R11b, R11c, R11d, X, n1, n2, and n3 are as defined herein, are provided. Uses of such compounds for modulating androgen receptor activity, imaging diagnostics in cancer and therapeutics, and methods for treatment of subjects in need thereof, including prostate cancer are also provided.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully